Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
98.5M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
106M
-
Shares change
-
+13M
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$160M
-
Put/Call ratio
-
4.92
-
Number of buys
-
89
-
Number of sells
-
-55
-
Price
-
$12.00
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q3 2025
176 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 106M shares
.
Largest 10 shareholders include Nextech Invest, Ltd. (7.16M shares), EcoR1 Capital, LLC (6.73M shares), VR ADVISER, LLC (6.6M shares), VIKING GLOBAL INVESTORS LP (6.57M shares), Pfizer Inc (5.38M shares), BlackRock, Inc. (5.28M shares), VANGUARD GROUP INC (4.65M shares), SR One Capital Management, LP (4.51M shares), ALKEON CAPITAL MANAGEMENT LLC (4.5M shares), and NEA Management Company, LLC (4.12M shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.